Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary

European Journal of Cancer

Volumn 31, Issue 11, 1995, Pages 1890-1891

  Culine, S ^a   Lhomme, C ^a   Farhat, F ^a   Droz, J P ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; FEMALE; GERM CELL TUMOR; HUMAN; LETTER; OVARY CANCER; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMAN; MIDDLE AGE; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; SALVAGE THERAPY;

EID: 0028839328     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00371-O     Document Type: Letter

References (8)

1. Current management of ovarian germ cell tumours
2. Update on malignant ovarian germ cell tumours
3. Ifosfamide in refractory male germ cell tumors
4. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide
5. The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumours
6. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma
7. Salvage chemotherapy in refractory germ cell tumor with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen
8. Role of autologous bone marrow transplantation in germ-cell cancer